Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult Use
ApprovedCompleted 0 watching 0 views this week🔥 Hot
84
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Tetanus
Conditions
Tetanus, Diphtheria, Pertussis, Whooping Cough
Trial Timeline
Nov 1, 2011 → Feb 1, 2017
NCT ID
NCT01439165About Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult Use
Tetanus Toxoid, Diphtheria Toxoid and Pertussis Vaccine + Tetanus and Diphtheria Toxoids Adsorbed For Adult Use is a approved stage product being developed by Sanofi for Tetanus. The current trial status is completed. This product is registered under clinical trial identifier NCT01439165. Target conditions include Tetanus, Diphtheria, Pertussis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
9
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01439165 | Approved | Completed |
Competing Products
10 competing products in Tetanus